10 Biotech Stocks to Buy According to Matthew Strobeck's Birchview Capital
In this article, we discuss 10 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Acceleron Pharma Inc (XLRN)
This company is not actively trading or the ticker does belong to another company in our database now.
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Squarepoint Ops LLC Maxime Fortin (Cio) | 0 | $0 | 0% | |
| 2. | Walleye Capital Will England | 0 | $0 | 0% | |
| 3. | Eversept Partners Kamran Moghtaderi | 0 | $0 | 0% | |
| 4. | Jasper Ridge Partners Mark Wolfson And Jamie Alexander | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $92.50 | 108,108 | $9,999,990.00 | 6,971,772 | 2020-07-01 | Filing | |
| $38.05 | 5,000 | $190,250.00 | 12,750 | 2019-06-14 | Filing | |
| $43.00 | 706,206 | $30,366,858.00 | 6,824,685 | 2019-01-18 | Filing | |
| $37.00 | 745,592 | $27,586,904.00 | 6,118,479 | 2017-09-25 | Filing | |
| $25.50 | 4,000 | $102,000.00 | 4,000 | 2016-12-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $175.00 | 5,000 | $875,000.00 | 18,509 | 2021-09-27 | Filing | |
| $160.38 | 5,370 | $861,240.60 | 10,681 | 2021-09-24 | Filing | |
| $161.26 | 983 | $158,518.58 | 10,681 | 2021-09-23 | Filing | |
| $160.26 | 18,647 | $2,988,368.22 | 11,664 | 2021-09-23 | Filing | |
| $150.05 | 6,650 | $997,832.50 | 18,923 | 2021-09-21 | Filing |
Institutional Investors' Holdings
News See All
5 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors
In this article, we take a look at the 5 pharmaceutical stocks to buy according to Brandon Haley’s Holocene Advisors.
Here's Why You Should Consider Investing in Acceleron Pharma (XLRN)
Baron Funds, an asset management firm, published its “Baron Health Care Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Are Buying Acceleron Pharma Inc (XLRN)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious...
Analysts are Raising Price Targets of These 10 Stocks
In this article, we discuss the 10 stocks that analysts are raising price targets of.
Hedge Fund and Insider Trading News: Generation Investment Management, Starboard Value LP, Black-and-White Capital, Marriott International Inc (MAR), Acceleron Pharma Inc (XLRN), and More
Activist investing can be a lonely slog in the Middle East.
Baron Funds: "Acceleron (XLRN) Remains a Top Pick, We Have Not Changed Our Conviction"
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Here is What Hedge Funds Think About Acceleron Pharma Inc (XLRN)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
10 Best Pharmaceutical Stocks to Buy According to Billionaire Kerr Neilson
In this article we will take a look at the 10 best pharmaceutical stocks to buy according to billionaire Kerr Neilson.
Is XLRN Stock A Buy or Sell?
We at Insider Monkey have gone over 887 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of December...
Hedge Fund Resource Center Billionaire Hedge Funds
